Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydroxyurea
Drug ID BADD_D01110
Description An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
Indications and Usage For management of melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and Sickle-cell anemia.
Marketing Status Prescription; Discontinued
ATC Code L01XX05
DrugBank ID DB01005
KEGG ID D00341
MeSH ID D006918
PubChem ID 3657
TTD Drug ID D07CWD
NDC Product Code 70518-0916; 0904-6939; 51927-0072; 49452-3650; 0003-6337; 60429-265; 55154-7143; 0003-0830; 10135-702; 71770-120; 49884-724; 55512-0003; 68084-284; 51552-0851; 17337-0022; 0003-6336; 35369-0006; 0555-0882; 0003-6335; 42291-321; 51927-2655; 71052-323; 69315-164; 17337-0023; 71770-105
Synonyms Hydroxyurea | Hydroxycarbamid | Oncocarbide | Hydrea
Chemical Information
Molecular Formula CH4N2O2
CAS Registry Number 127-07-1
SMILES C(=O)(N)NO
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Chronic myeloid leukaemiaTyrosine-protein kinase ABL1P00519T6350511841409; 11273186; 9516377; 15510207
HepatomegalyTyrosine-protein kinase ABL1P00519T6350511841409; 11273186; 9516377; 15510207
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Radiation skin injury23.03.11.007; 12.05.02.004--
Hypophagia19.09.01.004; 14.03.01.006; 07.01.06.0100.001066%Not Available
Blood count abnormal13.01.07.0010.001066%Not Available
Skin haemorrhage24.07.06.009; 23.06.07.0010.000533%Not Available
Osteonecrosis of jaw24.04.05.005; 15.02.04.010--
Chronic kidney disease20.01.03.0170.001332%
Pulmonary arterial hypertension22.06.01.002; 24.08.03.0030.001066%Not Available
Epstein-Barr viraemia11.05.10.0020.000139%Not Available
Bone marrow failure01.03.03.0050.004263%
Cytopenia01.03.03.0120.000139%Not Available
Treatment failure08.06.01.0170.000208%Not Available
Oral herpes07.05.07.002; 11.05.02.0050.000533%Not Available
Low birth weight baby18.04.02.0030.000799%Not Available
Nail atrophy23.02.05.010--Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.004--
Tongue pigmentation07.14.02.0170.000533%Not Available
Acute kidney injury20.01.03.016--
Sperm concentration decreased13.20.01.0080.000799%Not Available
Leukostasis syndrome01.02.01.011; 22.01.03.008; 17.02.10.018; 16.32.03.0180.000533%Not Available
Multiple organ dysfunction syndrome08.01.03.0570.000208%
Myeloproliferative neoplasm16.21.03.006; 01.13.03.0060.000208%Not Available
Angiosarcoma16.16.03.001; 24.03.06.0030.000533%Not Available
Central nervous system lymphoma16.20.01.005; 01.12.01.0050.000139%Not Available
Concomitant disease aggravated08.01.03.0630.001066%Not Available
Hypergammaglobulinaemia benign monoclonal16.23.01.004; 01.14.01.0040.000533%Not Available
Infected skin ulcer23.07.03.017; 11.01.12.0250.000533%Not Available
Metastases to lymph nodes01.09.01.015; 16.22.02.0060.000139%Not Available
Normal newborn18.08.06.0010.000799%Not Available
Splenic haematoma12.01.02.013; 01.09.02.014; 24.07.01.0790.000208%Not Available
Squamous cell carcinoma of the oral cavity16.13.07.006; 07.21.07.0090.000139%Not Available
The 13th Page    First    Pre   13 14    Next   Last    Total 14 Pages